-
1
-
-
0030955346
-
Epidemiology of hepatitis C
-
Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26(suppl 1):62S-65S.
-
(1997)
Hepatology
, vol.26
, Issue.SUPPL. 1
-
-
Alter, M.J.1
-
2
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med, 1999;341:556-562.
-
(1999)
N Engl J Med
, vol.341
, pp. 556-562
-
-
Alter, M.J.1
Kruszon-Moran, D.2
Nainan, O.V.3
-
3
-
-
20244371123
-
Extrahepatic manifestations of hepatitis C among United States male veterans
-
El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439-1445.
-
(2002)
Hepatology
, vol.36
, pp. 1439-1445
-
-
El-Serag, H.B.1
Hampel, H.2
Yeh, C.3
Rabeneck, L.4
-
4
-
-
0026439201
-
A role for hepatitis C virus infection in type II cryoglobulinemia
-
Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-1495.
-
(1992)
N Engl J Med
, vol.327
, pp. 1490-1495
-
-
Agnello, V.1
Chung, R.T.2
Kaplan, L.M.3
-
5
-
-
0026674225
-
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia
-
Misiani R, Bellavita P, Fenili D, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med. 1992;117:573-577.
-
(1992)
Ann Intern Med
, vol.117
, pp. 573-577
-
-
Misiani, R.1
Bellavita, P.2
Fenili, D.3
-
6
-
-
0032475822
-
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy
-
Neumann AU, Lam NP, Dahati H, et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-a therapy. Science. 1998;282:103-107.
-
(1998)
Science
, vol.282
, pp. 103-107
-
-
Neumann, A.U.1
Lam, N.P.2
Dahati, H.3
-
12
-
-
0028274816
-
Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage
-
Lunel F, Musset L, Cacoub P, et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology. 1994;106:1291-1300.
-
(1994)
Gastroenterology
, vol.106
, pp. 1291-1300
-
-
Lunel, F.1
Musset, L.2
Cacoub, P.3
-
14
-
-
0346666717
-
Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients
-
Ni J, Hembrador E, Di Bisceglie AM, et al. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J Immunol. 2003;170:3429-3439.
-
(2003)
J Immunol
, vol.170
, pp. 3429-3439
-
-
Ni, J.1
Hembrador, E.2
Di Bisceglie, A.M.3
-
15
-
-
0036787033
-
Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas
-
Zignego AL, Ferri C, Giannelli F, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med. 2002;137:571-580.
-
(2002)
Ann Intern Med
, vol.137
, pp. 571-580
-
-
Zignego, A.L.1
Ferri, C.2
Giannelli, F.3
-
16
-
-
0033538468
-
BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
-
Moore PA, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science. 1999;285:260-263.
-
(1999)
Science
, vol.285
, pp. 260-263
-
-
Moore, P.A.1
Belvedere, O.2
Orr, A.3
-
17
-
-
0036732753
-
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
-
Litinskiy MB, Nardelli B, Hubert DM, et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002;3:822-829.
-
(2002)
Nat Immunol
, vol.3
, pp. 822-829
-
-
Litinskiy, M.B.1
Nardelli, B.2
Hubert, D.M.3
-
18
-
-
16544378081
-
The BAFF/APRIL system: An important player in systemic rheumatic diseases
-
Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun. 2005;8:243-265.
-
(2005)
Curr Dir Autoimmun
, vol.8
, pp. 243-265
-
-
Mackay, F.1
Sierro, F.2
Grey, S.T.3
Gordon, T.P.4
-
19
-
-
0036498694
-
The role of BAFF in B-cell maturation, T-cell activation and autoimmunity
-
Mackay F, Mackay CR. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002;23:113-115.
-
(2002)
Trends Immunol
, vol.23
, pp. 113-115
-
-
Mackay, F.1
Mackay, C.R.2
-
20
-
-
0035860559
-
An essential role for BAFF in the normal development of B ceils through a BCMA-independent pathway
-
Schiemann B, Gommerman JL, Vora K, et al. An essential role for BAFF in the normal development of B ceils through a BCMA-independent pathway. Science. 2001;293:2111-2114.
-
(2001)
Science
, vol.293
, pp. 2111-2114
-
-
Schiemann, B.1
Gommerman, J.L.2
Vora, K.3
-
21
-
-
0347285357
-
BCMA is essential for the survival of long-lived bone marrow plasma cells
-
O'Connor BP, Raman VS, Erickson LD, et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004;199:91-98.
-
(2004)
J Exp Med
, vol.199
, pp. 91-98
-
-
O'Connor, B.P.1
Raman, V.S.2
Erickson, L.D.3
-
22
-
-
0034596831
-
Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response
-
Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J Exp Med. 2000;192:953-964.
-
(2000)
J Exp Med
, vol.192
, pp. 953-964
-
-
Do, R.K.1
Hatada, E.2
Lee, H.3
-
23
-
-
85047690330
-
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
-
Avery DT, Kalled SL, Ellyard JI, et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest. 2003;112:286-297.
-
(2003)
J Clin Invest
, vol.112
, pp. 286-297
-
-
Avery, D.T.1
Kalled, S.L.2
Ellyard, J.I.3
-
24
-
-
1842633887
-
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
-
Lesley R, Xu Y, Kalled SL, et al. Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF. Immunity. 2004;20:441-453.
-
(2004)
Immunity
, vol.20
, pp. 441-453
-
-
Lesley, R.1
Xu, Y.2
Kalled, S.L.3
-
25
-
-
2942518502
-
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
-
Thien M, Phan TG, Gardam S, et al. Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004;20:785-798.
-
(2004)
Immunity
, vol.20
, pp. 785-798
-
-
Thien, M.1
Phan, T.G.2
Gardam, S.3
-
26
-
-
0034972257
-
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases
-
Cheema GS, Roschke V, Hubert DM, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44:1313-1319.
-
(2001)
Arthritis Rheum
, vol.44
, pp. 1313-1319
-
-
Cheema, G.S.1
Roschke, V.2
Hubert, D.M.3
Stohl, W.4
-
27
-
-
70350612907
-
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
-
Ittah M, Miceli-Richard C, Eric Gottenberg J, et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther. 2006;8:R51.
-
(2006)
Arthritis Res Ther
, vol.8
-
-
Ittah, M.1
Miceli-Richard, C.2
Eric Gottenberg, J.3
-
28
-
-
10744224617
-
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations
-
Stohl W, Metyas S, Tan SM, et al. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. Arthritis Rheum. 2003;48:3475-3486.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 3475-3486
-
-
Stohl, W.1
Metyas, S.2
Tan, S.M.3
-
29
-
-
0037386743
-
Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis
-
Tan SM, Xu D, Roschke V, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003;48:982-992.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 982-992
-
-
Tan, S.M.1
Xu, D.2
Roschke, V.3
-
30
-
-
7544245599
-
Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus
-
Sene D, Ghillani-Dalbin P, Thibault V, et al. Long-term course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol. 2004;31:2199-2206.
-
(2004)
J Rheumatol
, vol.31
, pp. 2199-2206
-
-
Sene, D.1
Ghillani-Dalbin, P.2
Thibault, V.3
-
31
-
-
33749514258
-
Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity
-
Toubi E, Gordon S, Kessel A, et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun. 2006;27:134-139.
-
(2006)
J Autoimmun
, vol.27
, pp. 134-139
-
-
Toubi, E.1
Gordon, S.2
Kessel, A.3
-
32
-
-
33845575045
-
B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection
-
Fabtis M, Quartuccio L, Sacco S, et al. B-lymphocyte stimulator (BLyS) up-regulation in mixed cryoglobulinaemia syndrome and hepatitis-C virus infection. Rheumatology (Oxford). 2007;46:37-43.
-
(2007)
Rheumatology (Oxford)
, vol.46
, pp. 37-43
-
-
Fabtis, M.1
Quartuccio, L.2
Sacco, S.3
-
33
-
-
4544298413
-
Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis
-
Milosević-Jovcić N, Ciric D, Hajduković- Dragojlović L, Mircetić V. Differences in the relationship of specificity to titre and functional affinity between circulating Ga- and pan-reactive IgM rheumatoid factors in rheumatoid arthritis. Rheumatology (Oxford). 2004;43:1190-1193.
-
(2004)
Rheumatology (Oxford)
, vol.43
, pp. 1190-1193
-
-
Milosević-Jovcić, N.1
Ciric, D.2
Hajduković- Dragojlović, L.3
Mircetić, V.4
-
34
-
-
33744495071
-
HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations
-
De Re V, Sansonno D, Simula MP, et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia. 2006;20:1145-1154.
-
(2006)
Leukemia
, vol.20
, pp. 1145-1154
-
-
De Re, V.1
Sansonno, D.2
Simula, M.P.3
-
35
-
-
0030965840
-
Role of repetitive antigen patterns for induction of antibodies against antibodies
-
Feht T, Bachmann MF, Bucher E, et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med. 1997;185:1785-1792.
-
(1997)
J Exp Med
, vol.185
, pp. 1785-1792
-
-
Feht, T.1
Bachmann, M.F.2
Bucher, E.3
-
36
-
-
0033867014
-
The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy
-
Dammacco F, Sansonno D, Piccoli C, et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. Semin Liver Dis. 2000;20:143-157.
-
(2000)
Semin Liver Dis
, vol.20
, pp. 143-157
-
-
Dammacco, F.1
Sansonno, D.2
Piccoli, C.3
-
37
-
-
0038185193
-
Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver
-
Curry MP, Golden-Mason L, Doherty DG, et al. Expansion of innate CD5pos B cells expressing high levels of CD81 in hepatitis C virus infected liver. J Hepatol. 2003;38:642-650.
-
(2003)
J Hepatol
, vol.38
, pp. 642-650
-
-
Curry, M.P.1
Golden-Mason, L.2
Doherty, D.G.3
-
38
-
-
0030829376
-
High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy
-
De Rosa G, Gobbo ML, De Renzo A, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol. 1997;55:77-82.
-
(1997)
Am J Hematol
, vol.55
, pp. 77-82
-
-
De Rosa, G.1
Gobbo, M.L.2
De Renzo, A.3
-
40
-
-
17644448915
-
Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas
-
Silvestri F, Barillari G, Fanin R, et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica. 1997;82:314-317.
-
(1997)
Haematologica
, vol.82
, pp. 314-317
-
-
Silvestri, F.1
Barillari, G.2
Fanin, R.3
-
41
-
-
9444296054
-
Hepatitis C virus and non-Hodgkin's lymphomas
-
Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol. 1996;94:544-550.
-
(1996)
Br J Haematol
, vol.94
, pp. 544-550
-
-
Mazzaro, C.1
Zagonel, V.2
Monfardini, S.3
-
42
-
-
3042767356
-
Mixed cryoglobulinemia: Demographic, clinical, and serologic features and survival in 231 patients
-
Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355-374.
-
(2004)
Semin Arthritis Rheum
, vol.33
, pp. 355-374
-
-
Ferri, C.1
Sebastiani, M.2
Giuggioli, D.3
-
43
-
-
0037063113
-
Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection
-
Hermine O, Lefrère F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347:89-94.
-
(2002)
N Engl J Med
, vol.347
, pp. 89-94
-
-
Hermine, O.1
Lefrère, F.2
Bronowicki, J.P.3
-
44
-
-
0033428703
-
Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations
-
Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190:1697-1710.
-
(1999)
J Exp Med
, vol.190
, pp. 1697-1710
-
-
Mackay, F.1
Woodcock, S.A.2
Lawton, P.3
-
45
-
-
13844306871
-
Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: Electrophysiologic follow-up study
-
Ammendola A, Sampaolo S, Ambrosone L, et al. Peripheral neuropathy in hepatitis-related mixed cryoglobulinemia: electrophysiologic follow-up study. Muscle Nerve. 2005;31:382-385.
-
(2005)
Muscle Nerve
, vol.31
, pp. 382-385
-
-
Ammendola, A.1
Sampaolo, S.2
Ambrosone, L.3
-
46
-
-
33747841969
-
Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection
-
Boukhris S, Magy L, Senga-mokono U, et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol. 2006;13:937-941.
-
(2006)
Eur J Neurol
, vol.13
, pp. 937-941
-
-
Boukhris, S.1
Magy, L.2
Senga-mokono, U.3
-
47
-
-
18744399909
-
Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: A model of infection-driven lymphomagenesis
-
Carbonari M, Caprini E, Tedesco T, et al. Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis. J Immunol. 2005;174:6532-6539.
-
(2005)
J Immunol
, vol.174
, pp. 6532-6539
-
-
Carbonari, M.1
Caprini, E.2
Tedesco, T.3
-
48
-
-
0028130633
-
Renal manifestations of hepatitis C virus infection
-
Johnson RJ, Willson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994;46:1255-1263.
-
(1994)
Kidney Int
, vol.46
, pp. 1255-1263
-
-
Johnson, R.J.1
Willson, R.2
Yamabe, H.3
-
49
-
-
0031823457
-
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis
-
D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54:650-671.
-
(1998)
Kidney Int
, vol.54
, pp. 650-671
-
-
D'Amico, G.1
-
50
-
-
33845592773
-
Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis
-
Roccatello D, Fornasieri A, Giachino O, et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis. 2007;49:69-82.
-
(2007)
Am J Kidney Dis
, vol.49
, pp. 69-82
-
-
Roccatello, D.1
Fornasieri, A.2
Giachino, O.3
-
51
-
-
85002153461
-
Hepatitis C, cryoglobulinemia, and cirrhosis: A meta-analysis
-
Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology. 2002;36(4 pt 1):978-985.
-
(2002)
Hepatology
, vol.36
, Issue.4 PART 1
, pp. 978-985
-
-
Kayali, Z.1
Buckwold, V.E.2
Zimmerman, B.3
Schmidt, W.N.4
-
52
-
-
4444312093
-
Cryoglobulinemia and progression of fibrosis in chronic HCV infection: Cause or effect?
-
Siagris D, Christofidou M, Tsamandas A, et al. Cryoglobulinemia and progression of fibrosis in chronic HCV infection: cause or effect? J Infect. 2004;49:236-241.
-
(2004)
J Infect
, vol.49
, pp. 236-241
-
-
Siagris, D.1
Christofidou, M.2
Tsamandas, A.3
-
53
-
-
33745572348
-
Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C
-
Saadoun D, Asselah T, Resche-Rigon M, et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology. 2006;43:1337-1345.
-
(2006)
Hepatology
, vol.43
, pp. 1337-1345
-
-
Saadoun, D.1
Asselah, T.2
Resche-Rigon, M.3
-
54
-
-
33646730482
-
Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach
-
Lee IN, Chen CH, Sheu JC, et al. Identification of complement C3a as a candidate biomarker in human chronic hepatitis C and HCV-related hepatocellular carcinoma using a proteomics approach. Proteomics. 2006;6:2865-2873.
-
(2006)
Proteomics
, vol.6
, pp. 2865-2873
-
-
Lee, I.N.1
Chen, C.H.2
Sheu, J.C.3
-
55
-
-
0028090092
-
Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors
-
Itoh K, Tanaka H, Shiga J, et al. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors. Am J Gastroenterol. 1994;89:2019-2024.
-
(1994)
Am J Gastroenterol
, vol.89
, pp. 2019-2024
-
-
Itoh, K.1
Tanaka, H.2
Shiga, J.3
-
56
-
-
0343183463
-
A new complement function: Solubilization of antigen-antibody aggregates
-
Miller GW, Nussenzweig V. A new complement function: solubilization of antigen-antibody aggregates. Proc Natl Acad Set U S A. 1975;72:418-422.
-
(1975)
Proc Natl Acad Set U S A
, vol.72
, pp. 418-422
-
-
Miller, G.W.1
Nussenzweig, V.2
-
57
-
-
0021796688
-
Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake
-
Takahashi N, Fujita T, Takata Y, Tamura N. Interaction of complement solubilized complexes with mouse peritoneal macrophages and their clearance and tissue uptake. Clin Exp Immunol. 1985;61:176-182.
-
(1985)
Clin Exp Immunol
, vol.61
, pp. 176-182
-
-
Takahashi, N.1
Fujita, T.2
Takata, Y.3
Tamura, N.4
-
58
-
-
0022352363
-
Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors
-
Petersen I, Baatrup G, Jepsen HH, Svehag SE. Complement-mediated solubilization of immune complexes and their interaction with complement C3 receptors. Complement. 1985;2:97-110.
-
(1985)
Complement
, vol.2
, pp. 97-110
-
-
Petersen, I.1
Baatrup, G.2
Jepsen, H.H.3
Svehag, S.E.4
-
59
-
-
0028512757
-
Complement mediated solubilization: Role of the complement in the clearance of circulating immune-complexes
-
Sanchez-Cuenca JM. Complement mediated solubilization: role of the complement in the clearance of circulating immune-complexes. Allergol Immunopathol (Madr). 1994;22:197-203.
-
(1994)
Allergol Immunopathol (Madr)
, vol.22
, pp. 197-203
-
-
Sanchez-Cuenca, J.M.1
-
60
-
-
0020628210
-
Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system
-
Skogh T, Stendahl O. Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system. Immunology. 1983;49:53-59.
-
(1983)
Immunology
, vol.49
, pp. 53-59
-
-
Skogh, T.1
Stendahl, O.2
-
61
-
-
0027365485
-
Decreased activity of complement-mediated immune complex clearance in hemodialysis patients
-
Inagi R, Miyata T, Hong K, et al. Decreased activity of complement-mediated immune complex clearance in hemodialysis patients. Clin Immunol Immunopathol. 1993;68:333-339.
-
(1993)
Clin Immunol Immunopathol
, vol.68
, pp. 333-339
-
-
Inagi, R.1
Miyata, T.2
Hong, K.3
-
62
-
-
33644847301
-
The mannan-binding lectin (MBL) pathway of complement activation: Biochemistry, biology and clinical implications
-
Jensenius JC. The mannan-binding lectin (MBL) pathway of complement activation: biochemistry, biology and clinical implications. Adv Exp Med Biol. 2005;564:21-22.
-
(2005)
Adv Exp Med Biol
, vol.564
, pp. 21-22
-
-
Jensenius, J.C.1
-
63
-
-
33845473916
-
Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-I) complex
-
Brown KS, Keogh MJ, Tagiuri N, et al. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-I) complex. Clin Exp Immunol. 2007;147:90-98.
-
(2007)
Clin Exp Immunol
, vol.147
, pp. 90-98
-
-
Brown, K.S.1
Keogh, M.J.2
Tagiuri, N.3
-
64
-
-
33845615869
-
Mannan binding lectin and viral hepatitis
-
Brown KS, Ryder SD, Irving WL, et al. Mannan binding lectin and viral hepatitis. Immunol Lett. 2007;108:34-44.
-
(2007)
Immunol Lett
, vol.108
, pp. 34-44
-
-
Brown, K.S.1
Ryder, S.D.2
Irving, W.L.3
-
65
-
-
35348968297
-
Clinical spectrum of chronic hepatitis C virus-related cryoglobulinemia in the US
-
Presented at, May 19-24, Washington, DC. Abstract M1838
-
Al Sibae M, Jacobson IM, Lake-Bakaar G. Clinical spectrum of chronic hepatitis C virus-related cryoglobulinemia in the US. Presented at Digestive Disease Week, May 19-24, 2007, Washington, DC. Abstract M1838.
-
(2007)
Digestive Disease Week
-
-
Al Sibae, M.1
Jacobson, I.M.2
Lake-Bakaar, G.3
-
66
-
-
0034782263
-
Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment
-
Schott P, Hartmann H, Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment. Histol Histopathol. 2001;16:1275-1285.
-
(2001)
Histol Histopathol
, vol.16
, pp. 1275-1285
-
-
Schott, P.1
Hartmann, H.2
Ramadori, G.3
-
67
-
-
0029551887
-
Guidelines for the management of essential mixed cryoglobulinemia
-
Tavoni A, Mosca M, Ferri C, et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol. 1995;13(suppl 13):S191-SI95.
-
(1995)
Clin Exp Rheumatol
, vol.13
, Issue.SUPPL. 13
-
-
Tavoni, A.1
Mosca, M.2
Ferri, C.3
-
68
-
-
0001451871
-
Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemta
-
Gordon AC, Edgar JD, Finch RG. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemta. J Infect. 1998;36:229-230.
-
(1998)
J Infect
, vol.36
, pp. 229-230
-
-
Gordon, A.C.1
Edgar, J.D.2
Finch, R.G.3
-
69
-
-
0036266581
-
Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: A case report and literature review
-
Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve. 2002;25:909-913.
-
(2002)
Muscle Nerve
, vol.25
, pp. 909-913
-
-
Boonyapisit, K.1
Katirji, B.2
-
70
-
-
0032972998
-
Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin
-
Misiani R, Bellavita P, Baio P, et al. Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin. Nephrol Dial Transplant. 1999;14:1558-1560.
-
(1999)
Nephrol Dial Transplant
, vol.14
, pp. 1558-1560
-
-
Misiani, R.1
Bellavita, P.2
Baio, P.3
-
71
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiftman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347:975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiftman, M.L.2
Reddy, K.R.3
-
72
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001;358:958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
-
73
-
-
33845449051
-
Peginterferon and ribavirin for chronic hepatitis C
-
Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006;355:2444-2451.
-
(2006)
N Engl J Med
, vol.355
, pp. 2444-2451
-
-
Hoofnagle, J.H.1
Seeff, L.B.2
-
74
-
-
14944373284
-
PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis
-
Cacoub P, Saadoun D, Limal N, et al. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum. 2005;52:911-915.
-
(2005)
Arthritis Rheum
, vol.52
, pp. 911-915
-
-
Cacoub, P.1
Saadoun, D.2
Limal, N.3
-
75
-
-
0038603204
-
Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20
-
Sansonno D, De Re V, Lauletta G, et al. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood. 2003;101:3818-3826.
-
(2003)
Blood
, vol.101
, pp. 3818-3826
-
-
Sansonno, D.1
De Re, V.2
Lauletta, G.3
-
76
-
-
33847366355
-
Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario
-
Cheung MC, Haynes AE, Meyer RM, et al. Rituximab in lymphoma: a systematic review and consensus practice guideline from Cancer Care Ontario. Cancer Treat Rev. 2007;33:161-176.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 161-176
-
-
Cheung, M.C.1
Haynes, A.E.2
Meyer, R.M.3
-
77
-
-
0028057250
-
Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20
-
Reff ME, Carner K, Chambers KS, et al. Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20. Blood. 1994;83:435-445.
-
(1994)
Blood
, vol.83
, pp. 435-445
-
-
Reff, M.E.1
Carner, K.2
Chambers, K.S.3
-
78
-
-
33747184593
-
Treatment of rheumatoid arthritis with rituximab: An update and possible indications
-
De Vita S, Quartuccio L. Treatment of rheumatoid arthritis with rituximab: an update and possible indications. Autoimmun Rev. 2006;5:443-448.
-
(2006)
Autoimmun Rev
, vol.5
, pp. 443-448
-
-
De Vita, S.1
Quartuccio, L.2
-
79
-
-
0036177103
-
Rituximab: Ongoing and future clinical development
-
Grillo-Lopez AJ, Hedrick E, Rashford M, Benyunes M. Rituximab: ongoing and future clinical development. Semin Oncol. 2002;29(1 suppl 2):105-112.
-
(2002)
Semin Oncol
, vol.29
, Issue.1 SUPPL. 2
, pp. 105-112
-
-
Grillo-Lopez, A.J.1
Hedrick, E.2
Rashford, M.3
Benyunes, M.4
-
80
-
-
0036674876
-
B cell-ablative therapy for the treatment of autoimmune diseases
-
Patel DD. B cell-ablative therapy for the treatment of autoimmune diseases. Arthritis Rheum. 2002;46:1984-1985.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1984-1985
-
-
Patel, D.D.1
-
81
-
-
10744226311
-
Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis
-
Lamprecht P, Lerin-Lozano C, Merz H, et al. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis. Ann Rheum Dis. 2003;62:1230-1233.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 1230-1233
-
-
Lamprecht, P.1
Lerin-Lozano, C.2
Merz, H.3
-
82
-
-
0037926826
-
Efficacy and safety of rituximab in type II mixed cryoglobulinemia
-
Zaja F, De Vita S, Mazzaro C, et al. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood. 2003;101:3827-3834.
-
(2003)
Blood
, vol.101
, pp. 3827-3834
-
-
Zaja, F.1
De Vita, S.2
Mazzaro, C.3
-
83
-
-
19944429904
-
Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis
-
Roccatello D, Baldovino S, Rossi D, et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant. 2004;19:3054-3061.
-
(2004)
Nephrol Dial Transplant
, vol.19
, pp. 3054-3061
-
-
Roccatello, D.1
Baldovino, S.2
Rossi, D.3
-
84
-
-
29344438003
-
Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients
-
Basse G, Ribes D, Kamar N, et al. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients. Transplantation. 2005;80:1560-1564.
-
(2005)
Transplantation
, vol.80
, pp. 1560-1564
-
-
Basse, G.1
Ribes, D.2
Kamar, N.3
-
85
-
-
33745631505
-
Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: Efficacy and safety in the absence of steroids
-
Quartuccio L, Soardo G, Romano G, et al. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids. Rheumatology (Oxford). 2006;45:842-846.
-
(2006)
Rheumatology (Oxford)
, vol.45
, pp. 842-846
-
-
Quartuccio, L.1
Soardo, G.2
Romano, G.3
-
86
-
-
33846243704
-
Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: Evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease
-
Lake-Bakaar G, Dustin L, McKeating J, et al. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood. 2007;109:845-846.
-
(2007)
Blood
, vol.109
, pp. 845-846
-
-
Lake-Bakaar, G.1
Dustin, L.2
McKeating, J.3
-
87
-
-
33646736312
-
Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient
-
Aksoy S, Abali H, Kilickap S, et al. Accelerated hepatitis C virus replication with rituximab treatment in a non-Hodgkin's lymphoma patient. Clin Lab Haematol. 2006;28:211-214.
-
(2006)
Clin Lab Haematol
, vol.28
, pp. 211-214
-
-
Aksoy, S.1
Abali, H.2
Kilickap, S.3
-
88
-
-
8444243285
-
Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP
-
Dai MS, Chao TY, Kao WY, et al. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP. Ann Hematol. 2004;83:769-774.
-
(2004)
Ann Hematol
, vol.83
, pp. 769-774
-
-
Dai, M.S.1
Chao, T.Y.2
Kao, W.Y.3
-
89
-
-
0347899282
-
Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma
-
Tsutsumi Y, Tanaka J, Kawamura T, et al. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma. Ann Hematol. 2004;83:58-60.
-
(2004)
Ann Hematol
, vol.83
, pp. 58-60
-
-
Tsutsumi, Y.1
Tanaka, J.2
Kawamura, T.3
-
90
-
-
0034799485
-
Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: Case report
-
Ng HJ, Lim LC. Fulminant hepatitis B virus reactivation with concomitant listeriosis after fludarabine and rituximab therapy: case report. Ann Hematol. 2001;80:549-552.
-
(2001)
Ann Hematol
, vol.80
, pp. 549-552
-
-
HJ, N.1
Lim, L.C.2
-
91
-
-
12544255423
-
Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab
-
Zell JA, Yoon EJ, Ignatius Ou SH, et al. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Anticancer Drugs. 2005;16:83-85.
-
(2005)
Anticancer Drugs
, vol.16
, pp. 83-85
-
-
Zell, J.A.1
Yoon, E.J.2
Ignatius, O.S.3
-
92
-
-
10244228057
-
Hepatitis B reactivation in a patient receiving radiolabeled rituximab
-
Soong YL, Lee KM, Lui HF, et al. Hepatitis B reactivation in a patient receiving radiolabeled rituximab. Ann Hematol. 2005;84:61-62.
-
(2005)
Ann Hematol
, vol.84
, pp. 61-62
-
-
Soong, Y.L.1
Lee, K.M.2
Lui, H.F.3
-
93
-
-
10744227909
-
Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: Necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy
-
Tsutsumi Y, Kawamura T, Saitoh S, et al. Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab: necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy. Leuk Lymphoma. 2004;45:627-629.
-
(2004)
Leuk Lymphoma
, vol.45
, pp. 627-629
-
-
Tsutsumi, Y.1
Kawamura, T.2
Saitoh, S.3
-
94
-
-
8444220528
-
Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab
-
Hernandez JA, Diloy R, Salat D, et al. Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab. Haematologica. 2003;88:ECR22.
-
(2003)
Haematologica
, vol.88
-
-
Hernandez, J.A.1
Diloy, R.2
Salat, D.3
-
95
-
-
22144436318
-
Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: Potential implications for future prophylaxis recommendations
-
Law JK, Ho JK, Hoskins PJ, et al. Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations. Leuk Lymphoma. 2005;46:1085-1089.
-
(2005)
Leuk Lymphoma
, vol.46
, pp. 1085-1089
-
-
Law, J.K.1
Ho, J.K.2
Hoskins, P.J.3
-
96
-
-
24044431565
-
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb
-
Sarrecchia C, Cappelli A, Aiello P. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. J Infect Chemother. 2005;11:189-191.
-
(2005)
J Infect Chemother
, vol.11
, pp. 189-191
-
-
Sarrecchia, C.1
Cappelli, A.2
Aiello, P.3
-
97
-
-
0042941863
-
Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy
-
Westhoff TH, Jochimsen F, Schmittel A, et al. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood. 2003;102:1930.
-
(2003)
Blood
, vol.102
, pp. 1930
-
-
Westhoff, T.H.1
Jochimsen, F.2
Schmittel, A.3
-
98
-
-
33644545429
-
Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy
-
Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43:209-220.
-
(2006)
Hepatology
, vol.43
, pp. 209-220
-
-
Yeo, W.1
Johnson, P.J.2
|